Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 11/20 | 0.39 |
| ▸ | F3 | P13726 | 11/20 | 0.39 |
| ▸ | F2 | P00734 | 8/20 | 0.39 |
| ▸ | F10 | P00742 | 8/20 | 0.39 |
| ▸ | F11 | P03951 | 8/20 | 0.39 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.37 |
| ▸ | MET | P08581 | 3/20 | 0.33 |
| ▸ | KDR | P35968 | 2/20 | 0.33 |
| ▸ | KLK1 | P06870 | 1/20 | 0.31 |
| ▸ | AKT1 | P31749 | 1/20 | 0.31 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4332030 | 0.93 | F7 (0.39) | F7F3F2F10F11 | |
| SCHEMBL2916733 | 0.89 | F7 (0.36) | F7F3F2F10F11 | |
| SCHEMBL2908389 | 0.88 | F7 (0.35) | F7F3F2F10F11 | |
| SCHEMBL2853599 | 0.87 | F7 (0.36) | F7F3F2F10F11 | |
| SCHEMBL2915392 | 0.86 | F7 (0.44) | F7F3F2F10F11 | |
| SCHEMBL2912583 | 0.85 | F7 (0.40) | F7F3F2F10F11 | |
| SCHEMBL4761375 | 0.85 | NR1H4 (0.37) | F7F3F2F10F11 | |
| SCHEMBL4332034 | 0.85 | F7 (0.37) | F7F3F2F10F11 | |
| SCHEMBL2846745 | 0.83 | F7 (0.44) | F7F3F2F10F11 | |
| SCHEMBL2916691 | 0.83 | F7 (0.35) | F7F3F2F10F11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7622585-B2 | Phenylglycinamide derivatives useful as anticoagulants | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-11-24 | — | — | US | disclosed |